François Martelet
Directeur Général chez SCANDION ONCOLOGY A/S
Postes actifs de François Martelet
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SCANDION ONCOLOGY A/S | Directeur Général | 02/01/2023 | - |
Ennovance Capital LLC
 Ennovance Capital LLC Investment ManagersFinance Ennovance Capital LLC (Ennovance Capital) is a private equity firm founded in 2008. The firm is headquartered in Philadelphia, Pennsylvania. | Corporate Officer/Principal | 27/01/2010 | - |
Novigenix SA
 Novigenix SA Medical SpecialtiesHealth Technology Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland. | Directeur/Membre du Conseil | 18/06/2019 | - |
| Independent Dir/Board Member | 18/06/2019 | - |
Historique de carrière de François Martelet
Anciens postes connus de François Martelet
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VIVESTO AB | Directeur Général | 15/03/2020 | 21/07/2022 |
| Investor Relations Contact | 15/03/2020 | 21/07/2022 | |
| NETSCIENTIFIC PLC | Directeur/Membre du Conseil | 08/06/2015 | 30/04/2019 |
| Directeur Général | 08/06/2015 | 30/04/2019 | |
| TOPOTARGET A/S | Directeur Général | 23/02/2010 | 30/08/2012 |
| Public Communications Contact | 27/05/2010 | 30/08/2012 | |
| AVAX TECHNOLOGIES, INC. | Directeur Général | 20/07/2007 | 01/01/2009 |
| President | 20/07/2007 | 01/01/2009 | |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/07/2005 | 01/12/2006 |
| NOVARTIS AG | Corporate Officer/Principal | 01/07/2003 | 01/07/2005 |
| ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
Formation de François Martelet
| University of Dijon | Doctorate Degree |
| Burgundy School of Business | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| France | 5 |
| Suisse | 3 |
Opérationnelle
| Chief Executive Officer | 5 |
| Corporate Officer/Principal | 4 |
| Chairman | 3 |
Sectorielle
| Health Technology | 12 |
| Consumer Services | 4 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| AVAX TECHNOLOGIES, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| VIVESTO AB | Health Technology |
| NETSCIENTIFIC PLC | Health Technology |
| SCANDION ONCOLOGY A/S | Health Technology |
| Entreprise privées | 8 |
|---|---|
Stallergenes SA
 Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Ennovance Capital LLC
Ennovance Capital LLC Investment ManagersFinance Ennovance Capital LLC (Ennovance Capital) is a private equity firm founded in 2008. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
| Université de Paris 5 René Descartes | Consumer Services |
Novigenix SA
Novigenix SA Medical SpecialtiesHealth Technology Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland. | Health Technology |
Vortex BioSciences, Inc.
 Vortex BioSciences, Inc. Medical SpecialtiesHealth Technology Vortex BioSciences, Inc. provides a solution for routine isolation and purification of Circulating Tumor Cells (CTC). It offers VTX-1, an automated system that isolates intact CTCs directly from whole blood with high recovery and high purity. The company was founded by Dino Di Carlo and Elodie Sollier and is headquartered in Pleasanton, CA. | Health Technology |
Glycotest, Inc.
 Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Electronic Technology |
ProAxsis Ltd.
 ProAxsis Ltd. Pharmaceuticals: MajorHealth Technology ProAxsis Ltd. manufactures and markets pharmaceutical products . It offers clinical research and research and development services. The company was founded by Lorraine Martin and Brian Walker in August 2013 and is headquartered in Belfast, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- François Martelet
- Expérience
